Cadbury chocolate Mondelez International was denounced by consumers at Twitter for "shrinkflation" after announcing that it would reduce its products' weight without shrinking the price.
A disgruntled customer pointed out that Cadbury was using change is for health reasons for the shift when obvious it's that it's for the profit margins.
All Cadbury chocolate bars sold in multipacks will shrink by the end of 2021 to reduce their calorie count but at the same price.
Popular treats such as Twirl, Crunchie, and Wispa bars will be limited to no more than 200 calories each when sold in four-packs.
However, bars sold individually will not change.
When asked why individual bars were unaffected, a company spokesperson said the Mondelez believed in making available "different portion sizes for different occasions."
UK managing director at Mondelez International Louise Stigant said that it plays its part in tackling obesity without compromising consumer choice.
Mondelez shrunk its Toblerone's weight from 200g to 150g in 2016 but reverted to the old weight in 2018 after it met opposition.
Gordon's law firm food and drink supply chain expert Mark Jones attributed the shrinkflation to the recession, adding that between January 2012 and June 2017, 2,529 products shrank in size without changes in the prices.


Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



